the purpose of our study was to verify the possibility of obtaining a reduction in the erythrocyte filtration rate and an improvement in the o2 tissue uptake in twenty patients suffering from insulin-dependent diabetes mellitus and diabetic angiopathy , randomly divided in two groups receiving pentoxifylline ( 1,200 mg/day for 30 days ) or a placebo solution , respectively .
C0011875
diabetic
C0030899
pentoxifylline